Quality of life as a predictor for change in disability in MS

Neurology. 2001 May 8;56(9):1250. doi: 10.1212/wnl.56.9.1250.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Disability Evaluation
  • Disease Progression
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / physiopathology*
  • Predictive Value of Tests
  • Quality of Life*
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins